Kim YC - Search Results

1

Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer.

Kim DW, Kim YC, Kovari BP, Martinez M, Miao R, Yu J, Mehta R, Strosberg J, Imanirad I, Kim RD. Kim DW, et al. Among authors: kim rd, kim yc. Cancers (Basel). 2024 Jan 28;16(3):556. doi: 10.3390/cancers16030556. Cancers (Basel). 2024. PMID: 38339307 Free PMC article.

2

Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.

Abuodeh Y, Naghavi AO, Ahmed KA, Venkat PS, Kim Y, Kis B, Choi J, Biebel B, Sweeney J, Anaya DA, Kim R, Malafa M, Frakes JM, Hoffe SE, El-Haddad G. Abuodeh Y, et al. World J Gastroenterol. 2016 Dec 21;22(47):10406-10414. doi: 10.3748/wjg.v22.i47.10406. World J Gastroenterol. 2016. PMID: 28058021 Free PMC article.

3

A Randomized Trial of Precision Prevention Materials to Improve Primary and Secondary Melanoma Prevention Activities among Individuals with Limited Melanoma Risk Phenotypes.

Lacson JCA, Doyle SH, Qian L, Del Rio J, Forgas SM, Valavanis S, Carvajal R, Gonzalez-Calderon G, Kim Y, Roetzheim RG, Sutton SK, Vadaparampil ST, Kanetsky PA. Lacson JCA, et al. Cancers (Basel). 2021 Jun 23;13(13):3143. doi: 10.3390/cancers13133143. Cancers (Basel). 2021. PMID: 34201795 Free PMC article.

4

Geospatial Cellular Distribution of Cancer-Associated Fibroblasts Significantly Impacts Clinical Outcomes in Metastatic Clear Cell Renal Cell Carcinoma.

Chakiryan NH, Kimmel GJ, Kim Y, Johnson JO, Clark N, Hajiran A, Chang A, Aydin AM, Zemp L, Katende E, Chahoud J, Ferrall-Fairbanks MC, Spiess PE, Francis N, Fournier M, Dhillon J, Park JY, Wang L, Mulé JJ, Altrock PM, Manley BJ. Chakiryan NH, et al. Cancers (Basel). 2021 Jul 26;13(15):3743. doi: 10.3390/cancers13153743. Cancers (Basel). 2021. PMID: 34359645 Free PMC article.

5

A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer.

Kim RD, Kovari BP, Martinez M, Xie H, Sahin IH, Mehta R, Strosberg J, Imanirad I, Ghayouri M, Kim YC, Kim DW. Kim RD, et al. Among authors: kim dw, kim yc. Eur J Cancer. 2022 Jul;169:93-102. doi: 10.1016/j.ejca.2022.03.026. Epub 2022 May 5. Eur J Cancer. 2022. PMID: 35526308 Clinical Trial.

6

Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer.

Kim DW, Kim YC, Kovari BP, Chung V, Alese OB, El-Rayes BF, Li D, Park W, Kim RD. Kim DW, et al. Among authors: kim rd, kim yc. Eur J Cancer. 2022 Nov;176:171-180. doi: 10.1016/j.ejca.2022.09.014. Epub 2022 Sep 28. Eur J Cancer. 2022. PMID: 36252287 Clinical Trial.

7

A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer.

Zhang J, Gallaher J, Cunningham JJ, Choi JW, Ionescu F, Chatwal MS, Jain R, Kim Y, Wang L, Brown JS, Anderson AR, Gatenby RA. Zhang J, et al. Cancers (Basel). 2022 Oct 25;14(21):5225. doi: 10.3390/cancers14215225. Cancers (Basel). 2022. PMID: 36358643 Free PMC article.

8

Dichotomous Nitric Oxide-Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma.

Garg SK, Sun J, Kim Y, Whiting J, Sarnaik A, Conejo-Garcia JR, Phelps M, Weber JS, Mulé JJ, Markowitz J. Garg SK, et al. Cancers (Basel). 2023 Mar 14;15(6):1755. doi: 10.3390/cancers15061755. Cancers (Basel). 2023. PMID: 36980641 Free PMC article.

9

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma.

Marin-Acevedo JA, Withycombe BM, Kim Y, Brohl AS, Eroglu Z, Markowitz J, Tarhini AA, Tsai KY, Khushalani NI. Marin-Acevedo JA, et al. Cancers (Basel). 2023 Jun 14;15(12):3180. doi: 10.3390/cancers15123180. Cancers (Basel). 2023. PMID: 37370790 Free PMC article.

10

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma.

Kim DW, Beato F, Kim Y, Tassielli AF, Dai R, Denbo JW, Hodul PJ, Malafa MP, Fleming JB. Kim DW, et al. Oncotarget. 2023 Sep 15;14:811-818. doi: 10.18632/oncotarget.28508. Oncotarget. 2023. PMID: 37713330 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,306 results

Search Page

Filters